Portal de investigação
Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicals
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Mota, D
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 0105-4538, 1398-9995
- Tipo:
- Letter
- Páginas:
- 1375-1377
- DOI:
- 10.1111/all.15628
- Link para outro recurso:
- www.scopus.com
ALLERGY Wiley-Blackwell Publishing Ltd
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Keywords
- Biological Products; Humans; Neoplasms; benralizumab; dupilumab; interleukin 4 receptor alpha; interleukin 5; mepolizumab; reslizumab; biological product; breast cancer; cancer risk; colon cancer; cutaneous T cell lymphoma; human; Letter; lung cancer; lymphoma; major clinical study; Medical Dictionary for Regulatory Activities; melanoma; methodology; pancreas cancer; prostate cancer; risk assessment; unspecified side effect; neoplasm
Campos de estudo
Proyectos asociados
Airborne food and aeroallergens levels in healthcare settings. An unaccounted but potentially relevant source of exposure?
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (Aeroallergens) . 2020
Eosinophil cationic protein (ECP) correlates with eosinophil cell counts in the induced sputum of elite swimmers
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (ECP) . 2021
How exercise, physical activity and diet modulate immune and stress responses
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Mota D,Rama T,Moreira A. Real-world evidence on the risk of cancer with anti-IL-5 and anti-IL-4Ra biologicals. Allergy. 2023. 78(5):p. 1375-1377. IF:12,400. (1).
